Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. BAJAJHFL:I
9. CCHGY
10. PRY:IM

Go back to Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress

Agios Pharma (AGIO) Reports Q2 Loss Per Share of 85c

August 6, 2015 7:39 AM EDT

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($0.85), $0.39 worse than the analyst estimate of ($0.46).

"In the first half of 2015, we continued to drive rapid and meaningful progress across our development programs, as well as selecting our fourth molecule for development, AG-881, and... More